Purchase Order 75N98020P01593
Award Date 4/16/20
Potential Completion Date 4/15/21
Potential Value $682K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Beaverton, OR 97006, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institutes of Health's Office of Logistics and Acquisition Operations awarded a purchase order to Oregon Health & Science University for $214,692.00 on November 15, 2019, for Indian-origin rhesus macaques (mixed gender, specific-pathogen-free) in accordance with a statement of work. Performance occurs in Bethesda, Maryland, with an ultimate completion date of November 14, 2020. The order is firm fixed price with no set-aside applied.</p>
- This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Oregon Health & Science University (OHSU), an educational institution and state-controlled higher learning organization located in Oregon. The contract is for the procurement of 20 Rhesus macaque primates of Indian origin, greater than 4 years of age, and specified as special pathogen free (SPF) in accordance with...
- This is a $22,746.00 firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Oregon Health & Science University (OHSU) on August 23, 2022. The contract is for the delivery of rhesus macaque 1-cell stage embryos and has a completion date of September 30, 2022. The contract was not set aside for any specific business category. OHSU is a state-controlled institution of higher learning that has an...
- This is a Firm Fixed Price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Oregon Health & Science University (OHSU) for the provision of rhesus macaque 1-cell stage embryos. The contract has a ceiling value of $24,012.00 and a period of performance through November 30, 2023. No set-aside designation was used for this award. OHSU is a state-controlled institution of higher learning that has established itself as a...
- The Department of Health and Human Services National Institutes of Health (NIH) awarded a firm-fixed-price purchase order to Oregon Health & Science University (OHSU), a U.S. state government-controlled educational institution, for the provision of live animals that are not raised for food. The contract has a potential value of $345,481.50 and a completion date of July 15, 2020. No set-aside designation was used for this award. OHSU is a research-focused university that has received numerous...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $795,102.40 firm fixed price delivery order to Envigo Global Services Inc. under the Non-Human Primates 2016-2021 master indefinite-delivery/indefinite-quantity contract. Envigo will provide Rhesus monkeys of Indian origin, specific pathogen free, either gender weighing between 3-8 kilograms in accordance with request for quotation BD10. Performance will take place...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $22.2 million firm fixed price delivery order to Envigo Global Services Inc. under the Non-Human Primates 2016-2021 master indefinite-delivery/indefinite-quantity contract. Envigo will provide non-human primate research subjects, including rhesus monkeys of mixed gender in specific pathogen free condition, and their care per diem to support the National Institutes...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Envigo Global Services Inc. (a subsidiary of Laboratory Corporation of America Holdings) for $5,305.60. The contract is for the provision of research models, specifically non-human primates such as cynomolgus, rhesus, and Chinese-origin macaques, along with associated services including...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to World Wide Primates Inc., a for-profit Subchapter S corporation. The $125,000.00 award is for the supply of rhesus macaques of Chinese origin, 3 years of age and greater than 3 kilograms, with an even gender mix, in accordance with the requirements specified in Request for Quotation RM15. This...
- The Office of Logistics and Acquisition Operations (NIH) issued a delivery order to Envigo Global Services Inc. on October 31, 2018, with a ceiling value of $472,072.80 for the supply of Indian-origin rhesus macaques meeting specific health and pathogen criteria. The order is issued under the Non-Human Primates 2016-2021 IDV. The requirement specifies rhesus macaques of even gender, greater than 2 years of age, sourced from specific pathogen-free facilities, with two negative cultures for...
The National Institutes of Health awarded a $681,897 firm fixed price purchase order to Oregon Health & Science University, doing business as Ohsu, to deliver Indian origin rhesus macaques. The contract supports the Department of Health and Human Services and National Institutes of Health's efforts responding to the Coronavirus COVID-19 national interest. Performance will occur in Hillsboro, Oregon through April 15, 2021. No set aside designation or subcontractors were indicated. Ohsu will provide non-human primates to the NIH, likely in support of the agency's medical research into treatments and vaccines for COVID-19.
Generated 12/24/23, 11:53 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $681.9k | 4/16/20 |